Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Novel preparation method of Bosutinib avoiding hazardous chlorinating agents. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Discover the novel B(C6F5)3 catalyzed synthesis of 2,4,6-triaryl pyridines. A cost-effective, scalable solution for high-purity pharmaceutical and agrochemical intermediates.
Patent CN116003312B reveals a metal-free boron catalysis method for meta-selective pyridine functionalization, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel BF3-catalyzed route offers high yields and metal-free purification for scalable API intermediate production.
Patent CN110256211B reveals a photoredox method for 1,1-diarylalkane derivatives. Offers mild conditions and cost reduction in fine chemical manufacturing for global supply chains.
Patent CN110003299A details a novel THF-based synthesis for Betamethasone intermediates offering higher purity and reduced toxicity for reliable pharmaceutical supply chains.
Patent CN114276251A reveals a mild Lewis acid-catalyzed nitration method. Achieve high-purity nitroarenes with reduced waste and superior selectivity for API manufacturing.
Patent CN103145574A reveals a cost-effective Diclofenac route using N-chloroamide cyclization. Ideal for reliable pharmaceutical intermediates supplier seeking scalable API manufacturing.
Novel room-temperature method using metal triflates. High yield, recyclable catalyst, green solvents. Ideal for pharma intermediates.
Patent CN101735134A details a high-yield enantioselective cyclization method. Offers cost-effective routes for optically pure tetrahydropyrrole drugs.
Patent CN115785122A reveals a novel Lewis acid-catalyzed route to indole-piperidine scaffolds with high diastereoselectivity and potent MCF-7 cytotoxicity, offering a scalable solution for API manufacturing.
Novel Lewis acid catalyzed method for Meloxicam synthesis reduces reaction time and improves purity. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN102219739A reveals a high-yield FeCl3-catalyzed route to azaanthracenes, offering cost-effective manufacturing and reliable supply for pharmaceutical intermediates.
A novel two-step method for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yields and simplified purification for pharmaceutical supply chains.
Novel Lewis acid-catalyzed rearrangement offers mild conditions and high purity for pharmaceutical intermediate manufacturing and supply chain stability.
Novel mild method for 4H-pyrans using Lewis acids. High yield, broad substrate scope, ideal for pharma intermediates manufacturing.
Advanced synthesis method for Oseltamivir phosphate isomer impurity ensuring quality control. Reliable supplier for pharmaceutical intermediates with cost reduction.